Genomic characterization of clinical Borrelia burgdorferi sensu lato isolates in the Netherlands over a thirty-year period
This large-scale genomic analysis of clinical Dutch B. burgdorferi sl isolates furthers our understanding of LB and may indicate potential coverage for LB vaccine candidates in clinical development.
Authors
- Joppe W. Hovius (ORCID: https://orcid.org/0000-0003-0066-2437)
- Jonathan T. Lee (ORCID: https://orcid.org/0000-0002-9546-5294)
- Annaliesa S. Anderson (ORCID: https://orcid.org/0000-0002-6413-1718)
- Paul Liberator (ORCID: https://orcid.org/0000-0001-8298-5779)
- Alje P. van Dam (ORCID: https://orcid.org/0000-0003-3967-550X)
- Raphael Simon (ORCID: https://orcid.org/0000-0002-4136-0948)
- Lubomira Andrew
- Zhenghui Li (ORCID: https://orcid.org/0000-0002-7934-429X)
- Hao Li (ORCID: https://orcid.org/0000-0002-8865-7351)
- Amber Vrijlandt (ORCID: https://orcid.org/0000-0002-2296-4391)
- Urvi Rajyaguru
- Varun Raghuraman
- Katrina E. Llamera
- Lorna Nuñez
Institutions
- Pfizer (United States) (US)
- Amsterdam UMC Location University of Amsterdam (NL)
- Netherlands Center for Occupational Diseases (NL)
- Amsterdam Neuroscience (NL)
- Amsterdam University Medical Centers (NL)
Publication Details
- Journal
- BMC Genomics
- Published
- 2025-11-27
- DOI
- https://doi.org/10.1186/s12864-025-12357-4
- Citations
- 1
- Primary Topic
- Vector-borne infectious diseases
- Type
- article
- Field-Weighted Citation Impact
- 2.05
Funders
- Pfizer
- Amsterdam University Medical Centers